Ion Exchange (India) Earnings Call Transcript: Key Takeaways
Q2 FY27 EBITDA loss of ₹848 Mn and net loss of ₹828 Mn on ~8% revenue decline. Legacy-project overrun booked in one go. H2 recovery depends on deferred dispatches and the Hyundai order.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Q2 FY27 EBITDA loss of ₹848 Mn and net loss of ₹828 Mn on ~8% revenue decline. Legacy-project overrun booked in one go. H2 recovery depends on deferred dispatches and the Hyundai order.
Q2 FY27 consolidated operating loss: operating income INR 6,747 Mn (-8.1% YoY), EBITDA INR (848) Mn, PAT INR (828) Mn, driven by legacy project cost revisions.
Ion Exchange reported Q1 FY27 consolidated revenue of INR 701 Cr (+20% YoY) but a sharp decline in EBITDA to INR 32 Cr (-49%) and PAT to INR 3 Cr (-90%).
Ion Exchange is repositioning from an EPC-heavy firm to a product and services leader, though legacy project losses and Roha plant ramp-up costs are currently suppressing margins despite healthy revenue growth.
Ion Exchange (India) Limited's FY 2026-27 presentation highlights its leadership in total water and environment management, boasting 62+ years of expertise and operations in 50+ countries.
Ion Exchange reported Q4 FY26 consolidated revenue of INR 8,633 million (up 3%) and PAT of INR 243 million. Management is focusing on scaling the new Roha resin facility and international project execution.
ION Exchange reports steady revenue growth but significant margin pressure in its chemical segment due to raw material inflation and West Asia logistics disruptions.
Ion Exchange reported FY26 consolidated revenue of INR 29,148 Mn and PAT of INR 1,432 Mn. Performance was impacted by the West Asia crisis affecting logistics and input cost pressures.